| Entry |
|
|---|
| Name |
Aminolevulinic acid hydrochloride (JAN/USAN);
5-Aminolevulinic acid hydrochloride;
Levulan (TN);
Ameluz (TN);
Gleolan (TN)
|
|---|
| Product |
|
|---|
| Formula |
C5H9NO3. HCl
|
|---|
| Exact mass |
167.0349
|
|---|
| Mol weight |
167.5908
|
|---|
| Structure |
   |
|---|
| Simcomp |
 |
|---|
| Remark |
| Therapeutic category: | 7290 |
| Product (DG00708): | D02908<JP/US> |
|
|---|
| Efficacy |
Diagnostic (malignant glioma), Photosensitizer |
|---|
| Disease |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XD Sensitizers used in photodynamic/radiation therapy
L01XD04 Aminolevulinic acid
D02908 Aminolevulinic acid hydrochloride (JAN/USAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
7 Agents not mainly for therapeutic purpose
72 Intracorporeal diagnostic agents
729 Miscellaneous
7290 Miscellaneous
D02908 Aminolevulinic acid hydrochloride (JAN/USAN)
Antineoplastics [br08340.html]
D02908
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02908
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D02908
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02908
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02908
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 10
1 N1a N 11.5500 -5.7400
2 C1b C 10.2900 -5.0400
3 C5a C 9.1000 -5.7400
4 C1b C 7.9100 -5.0400
5 C1b C 6.6500 -5.7400
6 C6a C 5.4600 -5.0400
7 O6a O 4.2700 -5.7400
8 O6a O 5.4600 -3.6400
9 O5a O 9.1000 -7.1400
10 X Cl 15.0500 -5.8800
BOND 8
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 6 7 1
7 6 8 2
8 3 9 2
|
|---|
